The target audience for this annual, one-day educational program includes students, postdoctoral fellows and technicians from academia and industry, as well as physicians and scientists at more senior levels who wish to solidify their understanding of tumor immunology and immunotherapy, pharmacists and registered nurses.
At the conclusion of this activity, participants should be able to:
- Describe the key principles of tumor immunology and immunotherapy
- Review current approaches to immunotherapy including immune checkpoint modulation, activation of myeloid cells, modulation of tumor metabolism, T/NK cell adoptive transfer and bispecific antibodies
- Outline immune monitoring techniques as well as biomarker strategies and their role in trial design and patient selection
- Enhance scientific exchange with colleagues and collaborators on research and application of cancer immunotherapies to improve outcomes of patients with cancer
This program will be accredited to offer CME, CNE, CPE and MOC credits.